An accelerated approval for Zydus Cadila’s COVID-19 vaccine from India's regulator has given the company global bragging rights to the first plasmid DNA vaccine for use in humans. Zy-CoV-D also becomes the first coronavirus vaccine to be given a nod for use in adolescents aged from 12 to 18 in India.
Surely that’s good press and something the Indian firm can rightfully list as a significant achievement, but Zydus Cadila will...






